Clinical Trial Update: Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. [Phase 2]

View source ↗

Summary

This multicenter Phase II study evaluates a ctDNA- and PET-guided therapy approach in patients with diffuse large B-cell lymphoma. The trial is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING